ImmuCell Corporation, a prominent animal health developer, manufacturer, and distributor based in Portland, Maine, has expanded its reach beyond the borders of the United States. Its products, which are tailor-made to enhance the productivity and health of both dairy and beef cattle, have made their way into international markets. Among these products are First Defense, a revolutionary scours preventive medication given orally to newborn calves from both beef and dairy breeds, as well as Tri-Shield First Defense, a passive antibody product designed to combat E. coli, coronavirus, and rotavirus. The California Mastitis Test, one of ImmuCell Corporation's primary innovations, is used to detect somatic cell counts in milk, identify which quarter of the udder is mastitic, and determine the appropriate course of treatment. Other products, such as Dual-Force First Defense, which includes a whey protein concentrate for nutritional and feed supplement markets, have been developed for a variety of animal health challenges. In addition, the animal health giant is involved in developing Re-Tain, an intramammary treatment of subclinical mastitis in lactating dairy cows that's based on nisin. ImmuCell Corporation markets its products through various animal health distributors in the United States and abroad. ImmuCell Corporation was founded in 1982 and is headquartered in Portland, Maine.
ImmuCell's ticker is ICCC
The company's shares trade on the NASDAQ stock exchange
They are based in Portland, Maine
There are 51-200 employees working at ImmuCell
It is immucell.com
ImmuCell is in the Healthcare sector
ImmuCell is in the Biotechnology industry
The following five companies are ImmuCell's industry peers: